Methylene blue for burn-induced vasoplegia: Case report and review of literature

Journal of Burn Care and Research

Volumn 36, Issue 2, 2015, Pages e107-e111

  Church, Joseph T ^a   Posluszny, Joseph A ^a   Hemmila, Mark ^a   To, Kathleen B ^a   Cherry Bukowiec, Jill R ^a   Waljee, Jennifer ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; NITRIC OXIDE; NORADRENALIN; VASOPRESSIN; ENZYME INHIBITOR;

ADULT; BURN; BURN INDUCED VASOPLEGIA; CARDIOGENIC SHOCK; CASE REPORT; CONTINUOUS RENAL REPLACEMENT THERAPY; DISTRESS SYNDROME; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; FLUID RESUSCITATION; HUMAN; HYPOTENSION; KIDNEY FAILURE; LIQUID; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MUCORMYCOSIS; PNEUMONIA; REVIEW; SEPTIC SHOCK; SKIN GRAFT; SURVIVAL; VASOPLEGIA; BURNS; COMPLICATION; EVIDENCE BASED MEDICINE; TREATMENT FAILURE;

BURNS; ENZYME INHIBITORS; EVIDENCE-BASED MEDICINE; HUMANS; MALE; METHYLENE BLUE; MIDDLE AGED; TREATMENT FAILURE; VASOPLEGIA;

EID: 84923864673     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0000000000000134     Document Type: Review

References (20)

1. Park SH, Hemmila MR, Wahl WL. Early albumin use improves mortality in difficult to resuscitate burn patients. J Trauma Acute Care Surg 2012;73:1294-7
2. Lo JC, Darracq MA, Clark RF. A review of methylene blue treatment for cardiovascular collapse. J Emerg Med 2014
3. Weiner MM, Lin HM, Danforth D, Rao S, Hosseinian L, Fischer GW. Methylene blue is associated with poor outcomes in vasoplegic shock. J Cardiothorac Vasc Anesth 2013;27:1233-8
4. Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004;77:496-9
5. Kirov MY, Evgenov OV, Evgenov NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med 2001;29:1860-7
6. Acute and Chronic Inflammation. In: Kumar VAA, Fausto NF, editors. Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia: Elsevier Saunders; 2005
7. Farina Junior JA, Celotto AC, da Silva MF, Evora PR. Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis. Med Sci Monit 2012;18:HY13-7
8. Stawicki SP, Sims C, Sarani B, Grossman MD, Gracias VH. Methylene blue and vasoplegia: who, when, and how? Mini Rev Med Chem 2008;8:472-90
9. Evora PR, Ribeiro PJ, Vicente WV, et al. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties. Rev Bras Cir Cardiovasc 2009;24:279-88
10. Jaskille AD, Jeng JC, Jordan MH. Methylene blue in the treatment of vasoplegia following severe burns. J Burn Care Res 2008;29:408-10
11. Inoue H, Ando K, Wakisaka N, Matsuzaki K, Aihara M, Kumagai N. Effects of nitric oxide synthase inhibitors on vascular hyperpermeability with thermal injury in mice. Nitric Oxide 2001;5:334-42
12. Giladi AM, Kasten SJ. Anaphylactic-like reaction to methylene blue: case report and review of perioperative hypersensitivity reactions. Plast Reconstr Surg 2012;130:98e-105e
13. Dewachter P, Mouton-Faivre C, Tréchot P, Lleu JC, Mertes PM. Severe anaphylactic shock with methylene blue instillation. Anesth Analg 2005;101:149-50
14. Andresen M, Dougnac A, Díaz O, et al. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange. J Crit Care 1998;13:164-8
15. Kirov MY, Evgenov OV, Bjertnaes LJ. Combination of intravenously infused methylene blue and inhaled nitric oxide ameliorates endotoxin-induced lung injury in awake sheep. Crit Care Med 2003;31:179-86
16. Chen LW, Hwang YC, Chen CJ, Wang JS, Chen JS, Hsu CM. Burn-induced lung damage in rat is mediated by a nitric oxide/cGMP system. Shock 2003;20:369-74
17. - 2013 National Burn Repository. Available from http://ww wameriburnorg/2013NBRAnnualReportpdf; Internet
18. Tobiasen J, Hiebert JM, Edlich RF. The abbreviated burn severity index. Ann Emerg Med 1982;11:260-2
19. Moore EC, Pilcher DV, Bailey MJ, Stephens H, Cleland H. The Burns Evaluation and Mortality Study (BEAMS): predicting deaths in Australian and New Zealand burn patients admitted to intensive care with burns. J Trauma Acute Care Surg 2013;75:298-303
20. Ghanem AM, Sen S, Philp B, Dziewulski P, Shelley OP. Body Mass Index (BMI) and mortality in patients with severe burns: is there a "tilt point" at which obesity influences outcome? Burns 2011;37:208-14.